Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity

por Sturgill, Elizabeth R., Rolig, Annah S., Linch, Stefanie N., Mick, Courtney, Kasiewicz, Melissa J., Sun, Zhaoyu, Traber, Peter G., Shlevin, Harold, Redmond, William L.
Publicado 2021

Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis

por Noureddin, Mazen, Goodman, Zachary, Tai, Dean, Chng, Elaine L. K., Ren, Yayun, Boudes, Pol, Shlevin, Harold, Garcia‐Tsao, Guadalupe, Harrison, Stephen A., Chalasani, Naga P.
Publicado 2023

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

por Curti, Brendan D, Koguchi, Yoshinobu, Leidner, Rom S, Rolig, Annah S, Sturgill, Elizabeth R, Sun, Zhaoyu, Wu, Yaping, Rajamanickam, Venkatesh, Bernard, Brady, Hilgart-Martiszus, Ian, Fountain, Christopher B, Morris, George, Iwamoto, Noriko, Shimada, Takashi, Chang, ShuChing, Traber, Peter G, Zomer, Eliezer, Horton, J Rex, Shlevin, Harold, Redmond, William L
Publicado 2021